vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and iQSTEL Inc (IQST). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $84.2M, roughly 1.1× iQSTEL Inc). iQSTEL Inc runs the higher net margin — -3.2% vs -98.1%, a 94.9% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs -14.9%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 28.0%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.

HIVE vs IQST — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.1× larger
HIVE
$93.1M
$84.2M
IQST
Growing faster (revenue YoY)
HIVE
HIVE
+233.4% gap
HIVE
218.6%
-14.9%
IQST
Higher net margin
IQST
IQST
94.9% more per $
IQST
-3.2%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
28.0%
IQST

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
IQST
IQST
Revenue
$93.1M
$84.2M
Net Profit
$-91.3M
$-2.7M
Gross Margin
-27.1%
3.5%
Operating Margin
-2.9%
Net Margin
-98.1%
-3.2%
Revenue YoY
218.6%
-14.9%
Net Profit YoY
-234.0%
-44.5%
EPS (diluted)
$-0.38
$-0.92

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
IQST
IQST
Q4 25
$93.1M
$84.2M
Q3 25
$87.3M
$102.9M
Q2 25
$45.6M
$72.2M
Q1 25
$57.6M
Q4 24
$29.2M
$98.9M
Q3 24
$22.6M
$54.2M
Q2 24
$32.2M
$78.6M
Q1 24
$51.4M
Net Profit
HIVE
HIVE
IQST
IQST
Q4 25
$-91.3M
$-2.7M
Q3 25
$-15.8M
$-2.3M
Q2 25
$35.0M
$-2.3M
Q1 25
$-1.1M
Q4 24
$68.2M
$-1.9M
Q3 24
$80.0K
$-773.0K
Q2 24
$-18.3M
$-2.0M
Q1 24
$-580.2K
Gross Margin
HIVE
HIVE
IQST
IQST
Q4 25
-27.1%
3.5%
Q3 25
4.7%
2.7%
Q2 25
-13.6%
2.6%
Q1 25
3.4%
Q4 24
-43.7%
2.7%
Q3 24
-66.1%
3.7%
Q2 24
-7.4%
2.8%
Q1 24
2.7%
Operating Margin
HIVE
HIVE
IQST
IQST
Q4 25
-2.9%
Q3 25
-0.5%
Q2 25
-0.9%
Q1 25
-1.0%
Q4 24
-0.3%
Q3 24
-0.1%
Q2 24
-0.4%
Q1 24
-0.4%
Net Margin
HIVE
HIVE
IQST
IQST
Q4 25
-98.1%
-3.2%
Q3 25
-18.1%
-2.3%
Q2 25
76.8%
-3.3%
Q1 25
-2.0%
Q4 24
233.2%
-1.9%
Q3 24
0.4%
-1.4%
Q2 24
-56.7%
-2.5%
Q1 24
-1.1%
EPS (diluted)
HIVE
HIVE
IQST
IQST
Q4 25
$-0.38
$-0.92
Q3 25
$-0.07
$-0.68
Q2 25
$0.18
$-0.82
Q1 25
$-0.44
Q4 24
$0.52
$-1.19
Q3 24
$0.00
$-0.40
Q2 24
$-0.17
$-0.90
Q1 24
$-0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
IQST
IQST
Cash + ST InvestmentsLiquidity on hand
$2.2M
Total DebtLower is stronger
$4.1M
Stockholders' EquityBook value
$559.3M
$16.3M
Total Assets
$624.0M
$51.1M
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
IQST
IQST
Q4 25
$2.2M
Q3 25
$2.3M
Q2 25
$2.0M
Q1 25
$1.1M
Q4 24
$40.5M
$2.5M
Q3 24
$31.7M
$2.1M
Q2 24
$797.2K
Q1 24
$2.7M
Total Debt
HIVE
HIVE
IQST
IQST
Q4 25
$4.1M
Q3 25
$2.7M
Q2 25
$4.5M
Q1 25
$3.5M
Q4 24
$2.5M
Q3 24
$3.2M
Q2 24
$2.5M
Q1 24
$194.0K
Stockholders' Equity
HIVE
HIVE
IQST
IQST
Q4 25
$559.3M
$16.3M
Q3 25
$624.6M
$17.9M
Q2 25
$560.5M
$14.3M
Q1 25
$11.6M
Q4 24
$430.9M
$11.9M
Q3 24
$275.5M
$8.1M
Q2 24
$268.6M
$7.6M
Q1 24
$8.4M
Total Assets
HIVE
HIVE
IQST
IQST
Q4 25
$624.0M
$51.1M
Q3 25
$693.0M
$46.9M
Q2 25
$628.7M
$51.4M
Q1 25
$42.0M
Q4 24
$478.6M
$79.0M
Q3 24
$334.7M
$32.4M
Q2 24
$30.0M
Q1 24
$22.1M
Debt / Equity
HIVE
HIVE
IQST
IQST
Q4 25
0.25×
Q3 25
0.15×
Q2 25
0.31×
Q1 25
0.31×
Q4 24
0.21×
Q3 24
0.40×
Q2 24
0.34×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
IQST
IQST
Operating Cash FlowLast quarter
$46.0M
$-1.2M
Free Cash FlowOCF − Capex
$-1.2M
FCF MarginFCF / Revenue
-1.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-4.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
IQST
IQST
Q4 25
$46.0M
$-1.2M
Q3 25
$-10.6M
$-953.0K
Q2 25
$10.2M
$257.7K
Q1 25
$-1.9M
Q4 24
$-28.5M
$-403.7K
Q3 24
$-2.2M
$625.0K
Q2 24
$-4.4M
$-2.6M
Q1 24
$-536.9K
Free Cash Flow
HIVE
HIVE
IQST
IQST
Q4 25
$-1.2M
Q3 25
$-969.2K
Q2 25
$211.7K
Q1 25
$-2.0M
Q4 24
$-55.5M
$-421.3K
Q3 24
$-34.7M
$594.5K
Q2 24
$-2.6M
Q1 24
$-608.5K
FCF Margin
HIVE
HIVE
IQST
IQST
Q4 25
-1.5%
Q3 25
-0.9%
Q2 25
0.3%
Q1 25
-3.4%
Q4 24
-189.9%
-0.4%
Q3 24
-153.4%
1.1%
Q2 24
-3.4%
Q1 24
-1.2%
Capex Intensity
HIVE
HIVE
IQST
IQST
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
92.5%
0.0%
Q3 24
143.9%
0.1%
Q2 24
0.0%
Q1 24
0.1%
Cash Conversion
HIVE
HIVE
IQST
IQST
Q4 25
Q3 25
Q2 25
0.29×
Q1 25
Q4 24
-0.42×
Q3 24
-26.94×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIVE
HIVE

Segment breakdown not available.

IQST
IQST

USA$53.2M63%
Other$29.9M35%
Switzerland$1.1M1%

Related Comparisons